Our findings indicate that chronic cytokine “priming” of naïve CD4+ T cells in the circulation, which frequently precedes the clinical onset of RA (24), could indeed programme increased proliferative capacity and propensity for Th1-skewing upon subsequent antigen encounter, even when this occurs in tissue where IL-6 may no longer dominate. Here, CD4 is linked to rheumatoid arthritis.